Market Place
Sourcing Support
All News #Library
Biotech
RION Launches RION Vet Biologic, Names Mark Herthel as CEO
11 Nov 2025 //
BUSINESSWIRE
RION Engages Lonza for Scaling Exosome Based Therapeutics
23 Sep 2025 //
BUSINESSWIRE
RION`s INTENT Biologics to Develop Exosome-Based Therapies
09 Sep 2025 //
PHARMAWEB
Rion Aesthetics Backs First U.S. Clinical Trial of PEP™ Exosomes
03 Jun 2025 //
BUSINESSWIRE
RION Enrolls First Patient in Phase 1b Study for Knee Osteoarthritis
11 Mar 2025 //
BUSINESSWIRE
Rion Completes Enrollment In Ph 2 Study For PEP In Diabetic Ulcers
13 Jan 2025 //
BUSINESSWIRE
RION Initiates Phase 1b Study Of PEP™ For Knee Osteoarthritis
10 Sep 2024 //
BUSINESSWIRE
RION Doses First Patient In Phase 2 Exosome Study For Diabetic Ulcers
07 May 2024 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.